Insulin Resistance and Hyperinsulinemia Are Related to Plasma Aldosterone Levels in Hypertensive Patients
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—An association between aldosterone and insulin resistance has been demonstrated in obesity and primary aldosteronism and in blacks with the metabolic syndrome. The aim of this study was to evaluate the relationship of plasma aldosterone with insulin sensitivity in white subjects. RESEARCH DESIGN AND METHODS—In 356 patients with essential hypertension and 102 normotensive control subjects of comparable age and BMI, we measured, after discontinuation of treatment, plasma active renin, aldosterone, cortisol, glucose, insulin, and C-peptide levels and calculated markers of insulin sensitivity. Direct assessment of insulin sensitivity was obtained in a subset of 64 hypertensive patients by a hyperinsulinemic clamp. RESULTS—Hypertensive patients had significantly greater fasting plasma insulin and C-peptide concentrations and homeostasis model assessment (HOMA) indexes than normotensive control subjects. A positive association with increasing plasma aldosterone concentrations was demonstrated for plasma glucose, insulin, C-peptides, and HOMA. Assessment of insulin sensitivity by clamp showed a significant decrease of the metabolic clearance rate of glucose with increasing aldosterone levels. Significant correlations were found between plasma aldosterone, plasma insulin, and C-peptide levels, HOMA, and glucose metabolic clearance rate. Blood pressure and plasma potassium, plasma cortisol, and renin levels, but not BMI, were also directly correlated with plasma aldosterone. Multiple regression analysis showed that HOMA, together with plasma potassium, cortisol, and renin levels, was independently correlated with plasma aldosterone. CONCLUSIONS—This study demonstrates a direct relationship between aldosterone, insulin resistance, and hyperinsulinemia in white subjects. In patients with hypertension, this relationship might contribute to maintenance of high blood pressure and increased cardiovascular risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“However, the effects of hyperaldosteronism on insulin sensitivity and β-cell function are unclear.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“These assessments do not provide a robust estimation of insulin sensitivity when used alone.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
In the citing paper
“However, when compared with normotensive cohorts, reduced insulin sensitivity has been reported in PA patients [19,9,20,13,8,21,22].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [13]
Citations
Cites
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201
Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man
Rowe, J. W., Young, J. B., Minaker, K. L., Stevens, A. L., Pallotta, J., & Landsberg, L. (1981) · Diabetes · doi:10.2337/diab.30.3.219 · Cited by 1,143
Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A., & Mark, A. L. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115260 · Cited by 1,075
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
The Effect of Weight Loss on the Sensitivity of Blood Pressure to Sodium in Obese Adolescents
Rocchini, A. P., Key, J., Bondie, D., Chico, R., Moorehead, C., Katch, V., & Martin, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908313210905 · Cited by 621
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Cited by
Mechanisms linking obesity to hypertension
Dorresteijn, J. A. N., Visseren, F. L. J., & Spiering, W. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00914.x · Cited by 218
Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Muiesan, M. L., Salvetti, M., Paini, A., Agabiti-Rosei, C., Monteduro, C., Galbassini, G., Belotti, E., Aggiusti, C., Rizzoni, D., Castellano, M., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114140 · Cited by 126
Hoppmann, J., Perwitz, N., Meier, B., Fasshauer, M., Hadaschik, D., Lehnert, H., & Klein, J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 122
Wada, T., Ohshima, S., Fujisawa, E., Koya, D., Tsuneki, H., & Sasaoka, T. (2009) · Endocrinology · doi:10.1210/en.2008-1018 · Cited by 114
Effects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion
Gerards, J., Heinrich, D. A., Adolf, C., Meisinger, C., Rathmann, W., Sturm, L., Nirschl, N., Bidlingmaier, M., Beuschlein, F., Thorand, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00299 · Cited by 112
Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
Luther, J. M., Luo, P., Kreger, M. T., Brissova, M., Dai, C., Whitfield, T. T., Kim, H. S., Wasserman, D. H., Powers, A. C., & Brown, N. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2158-9 · Cited by 109
Akhlaghi, M. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422419000155 · Cited by 99
Krug, A. W., & Ehrhart‐Bornstein, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.109439 · Cited by 105
Aldosterone Production and Insulin Resistance in Healthy Adults
Garg, R., Hurwitz, S., Williams, G. H., Hopkins, P. N., & Adler, G. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2521 · Cited by 96
The Role of Aldosterone in the Metabolic Syndrome
Briet, M. B., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0182-2 · Cited by 101
Is Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry
Reincke, M., Meisinger, C., Holle, R., Quinkler, M., Hahner, S., Beuschlein, F., Bidlingmaier, M., Seissler, J., & Endres, S. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246189 · Cited by 98
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism
Fischer, E., Adolf, C., Pallauf, A., Then, C., Bidlingmaier, M., Beuschlein, F., Seissler, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3934 · Cited by 88
Food and Western Disease: Health and Nutrition from an Evolutionary Perspective
Lindeberg, S. (2009) · Wiley eBooks · doi:10.1002/9781444317176 · Cited by 114
Metabolic syndrome in hypertensive patients: An unholy alliance
Mulè, G., Calcaterra, I., Nardi, E., Cerasola, G., & Cottone, S. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.890 · Cited by 88
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
Otsuka, H., Abe, M., & Kobayashi, H. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065370 · Cited by 78
Genomic and rapid effects of aldosterone: what we know and do not know thus far
Hermidorff, M. M., de Assis, L. V. M., & Isoldi, M. C. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9591-2 · Cited by 75
Kumagai, E., Adachi, H., Jacobs, D. R., Hirai, Y., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S.-I., Nanjo, Y., Yoshikawa, K., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180521 · Cited by 65
Savarese, G., Lindberg, F., Filippatos, G. S., Butler, J., & Anker, S. D. (2023) · Diabetologia · doi:10.1007/s00125-023-06031-1 · Cited by 68
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism
Catena, C., Colussi, G., Fabio, A. D., Valeri, M., Marzano, L. A., Uzzau, A., & Sechi, L. A. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246185 · Cited by 62
Self-citationAssociation of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K.-H., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
Stiefel, P., Vallejo‐Vaz, A. J., Morillo, J. S. G., & Villar, J. (2011) · International Journal of Hypertension · doi:10.4061/2011/685238 · Cited by 61
Raimundo, M. R., & Lopes, J. A. (2011) · Cardiology Research and Practice · doi:10.4061/2011/747861 · Cited by 64
Bruder-Nascimento, T. B., Silva, M. A. B., & Tostes, R. C. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-90 · Cited by 55
Chen, W., Li, F., He, C., Zhu, Y., & Tan, W. (2014) · Irish Journal of Medical Science · doi:10.1007/s11845-013-1007-x · Cited by 53
The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic control
Perkins, J. M., & Davis, S. N. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282f7026f · Cited by 51
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 57
Aldosterone: A cardiovascular risk factor?
Funder, J. W., & Reincke, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.08.005 · Cited by 47
Selvaraj, J., Sathish, S., Mayilvanan, C., & Balasubramanian, K. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1452-2 · Cited by 47
Ebert, T., Anker, S. D., Ruilope, L. M., Fioretto, P., Fonseca, V. A., Umpierrez, G. E., Birkenfeld, A. L., Lawatscheck, R., Scott, C. A. B., Rohwedder, K., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1420 · Cited by 47
Nutrients other than carbohydrates: their effects on glucose homeostasis in humans
Heer, M. A., & Egert, S. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2533 · Cited by 48
Adverse Cardiovascular Outcomes of Corticosteroid Excess
Pimenta, E., Wolley, M. J., & Stowasser, M. (2012) · Endocrinology · doi:10.1210/en.2012-1573 · Cited by 49
Jin, H. M., Zhou, D. C., Gu, H. F., Qiao, Q. Y., Fu, S. K., Liu, X. L., & Pan, Y. (2013) · Endocrinology · doi:10.1210/en.2013-1115 · Cited by 40
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.167 · Cited by 39
Juutilainen, A., Savolainen, K., Romppanen, J., Turpeinen, U., Hämäläinen, E. K., Kemppainen, J., Moilanen, L., & Pulkki, K. J. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.03.015 · Cited by 38
Goyal, B. R., Solanki, N. D., Goyal, R. K., & Mehta, A. A. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181be75cc · Cited by 37
Vernooij, J. W. P., van der Graaf, Y., Nathoe, H. M., Bemelmans, R. H. H., Visseren, F. L. J., & Spiering, W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835cd3cd · Cited by 41
Soltani, Z., Washco, V., Morse, S., & Reisin, E. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0520-2 · Cited by 39
Freel, E. M., Tsorlalis, I. K., Lewsey, J., Latini, R., Maggioni, A. P., Solomon, S., Pitt, B., Connell, J., & McMurray, J. J. V. (2009) · Heart · doi:10.1136/hrt.2009.173344 · Cited by 36
Mule, G., Nardi, E., Cusimano, P., Cottone, S., Seddio, G., Geraci, C., Palermo, A., Andronico, G., & Cerasola, G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.225 · Cited by 34
Huan, Y., DeLoach, S. S., Keith, S. W., Goodfriend, T. L., & Falkner, B. E. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.09.005 · Cited by 35
Role of mineralocorticoid receptor in insulin resistance
Garg, R., & Adler, G. K. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283533955 · Cited by 35
Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro
Mao, N., Cheng, Y., Shi, X., Wang, L., Wen, J., Zhang, Q., Hu, Q., & Fan, J. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.187 · Cited by 31
Aldosterone induces clonal β-cell failure through glucocorticoid receptor
Chen, F., Liu, J., Wang, Y., Wu, T., Shan, W., Zhu, Y., & Han, X. (2015) · Scientific Reports · doi:10.1038/srep13215 · Cited by 34
Even, S., Dulak-Lis, M. G., Touyz, R. M., & Cat, A. N. D. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0013 · Cited by 34
Secondary diabetes mellitus due to primary aldosteronism
Moustaki, M., Paschou, S. Α., Vakali, E., & Vryonidou, A. (2022) · Endocrine · doi:10.1007/s12020-022-03168-8 · Cited by 30
Glucose Metabolism in Primary Aldosteronism
Remde, H., Hanslik, G., Rayes, N., & Quinkler, M. O. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565208 · Cited by 33
Hypertension, Insulin Resistance, and Aldosterone: Sex‐Specific Relationships
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2009.00084.x · Cited by 31
Kim, H. W., Lee, D. H., Lee, S. A., & Koh, G. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1001-5 · Cited by 29
Sato, A., & Fukuda, S. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.81 · Cited by 27
Bellili-Muñoz, N., Foucan, L., Fumeron, F., Mohammedi, K., Travert, F., Roussel, R., Balkau, B., Tichet, J., Marre, M., & ; the D.E.S.I.R. Study Group (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.44 · Cited by 27
Sato, A. (2015) · Hypertension Research · doi:10.1038/hr.2015.19 · Cited by 26
Inoue, K., Kitamoto, T., Tsurutani, Y., Saito, J., Omura, M., & Nishikawa, T. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.645488 · Cited by 28
AlSafar, H. S., Hassoun, A. A. K., Almazrouei, S., Kamal, W., Al‐Maini, M., Odama, U. O., & Rais, N. (2015) · Disease Markers · doi:10.1155/2015/536041 · Cited by 24
O’Seaghdha, C. M., Hwang, S., Vasan, R. S., Larson, M. G., Hoffmann, U., Wang, T. J., & Fox, C. S. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-3 · Cited by 23
Lee, I., Chiu, Y., Hwu, C., He, C., Chiang, F., Lin, Y., Assimes, T. L., Curb, J. D., & Sheu, W. H. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-43 · Cited by 30
Laffer, C. L., & Elijovich, F. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00423 · Cited by 23
Min, S. H., Kim, S., Jeong, I., Cho, H., Jeong, J., Lee, J., Kang, H., Kim, H.-S., Park, K. S., & Lim, S. K. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0200 · Cited by 23
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
A Bibliometric Analysis of Primary Aldosteronism Research From 2000 to 2020
Wang, C., Jing, H., Sun, Z., Yao, J., Zhang, X., Liu, T., & Wu, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.665912 · Cited by 20
Effects of Primary Aldosteronism and Different Therapeutic Modalities on Glucose Metabolism
Kwak, M. K., Lee, J. Y., Kim, B., Lee, S. H., & Koh, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122194 · Cited by 19
Increased aldosterone among HIV-infected women with visceral fat accumulation
Lo, J., Looby, S. E. D., Wei, J., Adler, G. K., & Grinspoon, S. K. (2009) · AIDS · doi:10.1097/qad.0b013e3283328d3b · Cited by 19
Aldosterone and type 2 diabetes mellitus
Zavatta, G., Casadio, E., Rinaldi, E., Pagotto, U., Pasquali, R., & Vicennati, V. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0065 · Cited by 18
Gendreitzig, P., Kunzel, H. E., Adolf, C., Handgriff, L., Müller, L., Holler, F., Sturm, L., Heinrich, D. A., Reincke, M., & Quinkler, M. O. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab099 · Cited by 18
Lin, Y.-F., Peng, K., Chang, C., Hu, Y., Wu, V., Chung, S., & Taiwan Primary Aldosteronism Investigation (TAIPAI) Study Group (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.797 · Cited by 18
Wang, W., Wu, T.-H., Er, L., Huang, C., Tu, K., Fan, K., Tsai, C., Wang, S., Wu, C.-Y., Huang, S.-H., et al. (2024) · Hypertension Research · doi:10.1038/s41440-023-01538-x · Cited by 17
Adrenal steroids and the metabolic syndrome
Thomson, S. P., Stump, C. S., Kurukulasuriya, L. R., & Sowers, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0093-4 · Cited by 19
Cardiometabolic crosstalk in obesity-associated arterial hypertension
Jordan, J., & Birkenfeld, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9348-1 · Cited by 20
Aldosterone and Metabolic Dysfunction: An Unresolved Issue
Pimenta, E., & Calhoun, D. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.123406 · Cited by 17
Huang, C. L., Chang, L., Sheu, J.-Y., Huang, Y., Chen, J., Lai, C., & Wu, V. (2025) · Hypertension Research · doi:10.1038/s41440-025-02172-5 · Cited by 16
Prevalence of Primary Aldosteronism in Hypertensive Subjects with Hyperglycemia
Li, N., Wang, M., Wang, H., Zhang, D., Wang, X., Zu, F.-Y., Chang, G., & Zhou, K. (2012) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2012.712175 · Cited by 18
Pancreatic functions in high salt fed female rats
Lasheen, N. N. (2015) · Physiological Reports · doi:10.14814/phy2.12443 · Cited by 15
Kopprasch, S., Pietzsch, J., Ansurudeen, I., Graessler, J., Krug, A. W., Ehrhart‐Bornstein, M., & Bornstein, S. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0293 · Cited by 16
Impact of primary aldosteronism on renal function in patients with type 2 diabetes
Katsuragawa, S., Tsurutani, Y., Takiguchi, T., Saito, J., & Nishikawa, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13332 · Cited by 13
Three months of Tai Chi Chuan exercise can reduce serum triglyceride and endothelin-1 in the elderly
Lu, W.-A., & Kuo, C. (2013) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2013.06.007 · Cited by 12
Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus
Hiroi, N., Sue, M., Yoshihara, A., Ichijo, T., Yoshida-Hiroi, M., Higa, M., & Yoshino, G. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-71 · Cited by 13
Chen, K.-M., Lee, B., Chen, P., Liu, K., Lin, K., Chang, C., Wu, T.-H., Hong, J., & Lin, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.647184 · Cited by 13
Goyal, B. R., Bhadada, S. V., & Patel, M. M. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497705 · Cited by 11
Wang, L., Niu, Y., Wu, S., Zhang, C., Zhou, L., Zuo, H., & Wang, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00323 · Cited by 12
Han, M., Cao, X., Zhao, C., Yang, L., Yin, N., Shen, P., Zhang, J., Gao, F., Ren, Y., Liang, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.544752 · Cited by 10
Lastra‐González, G., Manrique‐Acevedo, C., & Sowers, J. R. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0035-9 · Cited by 10
Chung, Y., Tzeng, C., Chen, Y., Chang, S., Hsu, T., Ho, W., Kuo, Y., Hung, P., & Chang, S. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8259 · Cited by 12
Tsentidis, C., Bampilis, A., Ntova, V., Fragkos, D., Panos, C., Limniati, C., & Kassi, G. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0754-6464 · Cited by 10
Ohira, M., Kawagoe, N., Kameyama, C., Kondou, Y., Igarashi, M., & Ueshiba, H. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01706-8 · Cited by 8
NT-proBNP levels in patients with primary hyperaldosteronism and autonomous cortisol cosecretion
Hirsch, A., Adolf, C., Stüfchen, I., Beuschlein, F., Brüdgam, D., Bidlingmaier, M., Reincke, M., & Quinkler, M. O. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae119 · Cited by 10
Tsai, C., Wu, X.-M., Liao, C., Chen, Z., Pan, C., Chang, Y., Lee, B., Chiu, Y., Lai, T., Wu, V., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211066727 · Cited by 9
Korantzopoulos, P. G., Elisaf, M., & Milionis, H. J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm525 · Cited by 9
Handgriff, L., Adolf, C., Heinrich, D. A., Braun, L., Nirschl, N., Sturm, L., Ladurner, R., Ricke, J., Seidensticker, M., Bidlingmaier, M., et al. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1164-1944 · Cited by 9
Finerenone According to Insulin Resistance in Heart Failure: Insights from the FINEARTS-HF Trial
Ostrominski, J. W., Claggett, B. L., Desai, A. S., Jhund, P. S., Lam, C. S. P., Senni, M., Shah, S. J., Voors, A. A., Zannad, F. M., Pitt, B., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.70034 · Cited by 10
Obesity as a modifiable risk factor in patients with chronic kidney disease
Morales, E., Jenssen, T. G., Bevc, S., Miglinas, M., Martin, W. P., Theodorakopoulou, M. P., Jørgensen, M. B., & Trillini, M. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf231 · Cited by 10
Plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome
Mejía-Montilla, J., Reyna‐Villasmil, E., Torres-Cepeda, D., Santos-Bolívar, J., Reyna-Villasmil, N., & Bravo-Henríquez, A. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.09.003 · Cited by 7
Impact of Insulin Treatment on the Effect of Eplerenone: Insights From the EMPHASIS-HF Trial
Ferreira, J. P., Lamiral, Z., McMurray, J. J. V., Swedberg, K. B., van Veldhuisen, D. J., Vincent, J., Rossignol, P., Pocock, S., Pitt, B., & Zannad, F. M. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008075 · Cited by 7
Chen, U.-L., Liao, C., Wang, S., Lai, T., Huang, K., Chang, C., Lee, B., Lu, C., Chang, Y., Chang, Y., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589221141840 · Cited by 7
Mansour, N., Brüdgam, D., Dischinger, U., Kürzinger, L., Adolf, C., Walter, R., Öcal, O., Schmidt, V. F., Rudolph, J., Ricke, J., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.15013 · Cited by 9
Kao, C., Wu, V., Kuo, C.-C., Lin, Y., Hu, Y.-H., Tsai, Y., Wu, C., Wu, K., & TAIPAI study group (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312452767 · Cited by 7
Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population
Grytaas, M. A., Strømsøy, S., Rørvik, J. T., Arnes, J. B., Heie, A., Arnesen, T., Jørstad, M. D., Nedrebø, B. G., Jøssang, D. E., Jensen, D., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118909 · Cited by 9
Mansour, N., Brüdgam, D., Heinrich, D. A., Dischinger, U., Reisch, N., Völter, F., Stüfchen, I., Nowak, E., Zopp, S., Vasileva, V., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1521680 · Cited by 6
Punapart, M., Seppa, K., Jagomäe, T., Liiv, M., Reimets, R., Kirillov, S., Kaasik, A., Moons, L., Groef, L. D., Terasmaa, A., et al. (2021) · Genes · doi:10.3390/genes12111717 · Cited by 6
Metadata
- Authors
- Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A.
- Affiliations
- University of Udine (IT)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-09-01
- Volume
- 30
- Issue
- 9
- Pages
- 2349-2354
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2109111616
- Cited by
- 155
- References
- 47
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 11 · 2014: 11 · 2013: 9 · 2012: 10
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- Società Italiana dell'Ipertensione Arteriosa
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- insulin resistance, hyperinsulinemia, plasma aldosterone, essential hypertension, insulin sensitivity, C-peptide, HOMA, hyperinsulinemic-euglycemic clamp, glucose metabolic clearance rate, renin, cortisol, plasma potassium, cardiovascular risk
- MeSH terms
- Aged, Aldosterone, Cross-Sectional Studies, Female, Glucose, Humans, Hyperinsulinism, Hypertension, Insulin Resistance, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.